Meloxicam 13C6

[13C6]-Meloxicam is a labeled form of the nonsteroidal anti-inflammatory drug Meloxicam. This labeled compound is used for research and development purposes, specifically in pharmacokinetic and pharmacodynamic studies. The 13C6 label is used to distinguish the labeled compound from the unlabeled compound, making it easier to track and analyze its biological processes. Meloxicam is a potent inhibitor of cyclooxygenase-2 (COX-2), an enzyme involved in the production of prostaglandins, which are responsible for inflammation, pain, and fever. As a result, Meloxicam is used to treat conditions such as osteoarthritis, rheumatoid arthritis, and other inflammatory conditions. [13C6]-Meloxicam shares the same pharmacological properties as the parent compound, but its labeled form allows for more accurate and precise measurements in pharmacokinetic and metabolic studies. The chemical formula of [13C6]-Meloxicam is C15H11N3O4S2 and its molecular weight is 377.4 g/mol. The labeled compound is synthesized through a process of isotopic labeling, where 13C is introduced into the molecular structure of Meloxicam. The labeled compound is typically supplied as a white to off-white powder, and its purity is verified by various analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry (MS). Overall, the use of [13C6]-Meloxicam in research and development helps to advance our understanding of the pharmacological properties of Meloxicam and its efficacy in treating various inflammatory conditions.